Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

NCT07561567 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-05-01

No results posted yet for this study

Summary

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is:

Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors?

Participants will:

Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement

Conditions

  • Lung Cancer, Non-Small Cell

Interventions

DEVICE

Chest and abdominal compression

Abdominal compression suppresses respiratory movement in patients

DEVICE

breathing management

Apply pressure to the patient's abdomen to achieve respiratory movement inhibition

Sponsors & Collaborators

  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-10
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07561567 on ClinicalTrials.gov